Triplebar

Running Evolution at Hyper-Speed

Emeryville, United States · Founded 2019 · $20.0M raised

Employees
11–50
Founded
2019
Business Model
B2B
Total Funding
$20.0M
Last Round
$20.0M Venture Round
Rounds
1

About

Triplebar Bio, Inc. is a US-based biotechnology company that has developed a hyper-throughput biological screening platform combining droplet microfluidics and generative AI to rapidly discover breakthroughs for the world's most pressing challenges. Founded in 2019 by biochemist Dr. Jeremy Agresti, Triplebar analyzes billions of genetic variations daily to find optimal biological solutions at speeds and scales impossible with traditional methods. The platform runs evolution at hyper-speed, enabling development of novel enzymes, proteins, and bioproducts for applications including food and agriculture, sustainability, healthcare, and nutrition. In 2023, the company raised a $20M funding round.

Summary

Triplebar is a Biotech company based in Emeryville, United States, founded in 2019. It has raised $20.0M in total across 1 round. Investors include Synthesis Capital, Essential Capital and Stray Dog Capital.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Venture RoundFunding Round
$20.0M

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Triplebar on Indexed.vc
<a href="https://indexed.vc/companies/triplebar"><img src="https://indexed.vc/api/badge/company/triplebar" alt="Triplebar on Indexed.vc" width="260" height="76" /></a>